SCHEMBL5366271

SCHEMBL5366271

CC(C)(C)OC(=O)N1CCN(c2c(CN3CCCC3)cccc2C(F)(F)F)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 5/20 0.49
ABHD6 Q9BV23 3/20 0.49
PLA2G7 Q13093 2/20 0.49
FAAH O00519 2/20 0.47
KDM4E B2RXH2 5/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
ALOX15 P16050 2/20 0.45
POLB P06746 2/20 0.45
TP53 P04637 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
P2RX7 Q99572 2/20 0.44
ALDH1A1 P00352 6/20 0.44
TDP1 Q9NUW8 2/20 0.44
MAPT P10636 2/20 0.44
LMNA P02545 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5337966 0.84 MGLL (0.45) MGLLABHD6PLA2G7KDM4EP2RX7
SCHEMBL5335100 0.83 PLA2G7 (0.61) MGLLABHD6PLA2G7FAAHKDM4E
SCHEMBL28864301 0.83 ALDH1A1 (0.61) KDM4EMEN1KMT2AALOX15POLB
SCHEMBL5335298 0.82 MGLL (0.60) MGLLABHD6PLA2G7FAAHKDM4E
SCHEMBL15094716 0.81 MGLL (0.57) MGLLABHD6PLA2G7KDM4EMEN1
SCHEMBL17276635 0.80 MGLL (0.50) MGLLABHD6PLA2G7KDM4EMEN1
SCHEMBL5335251 0.80 MGLL (0.57) MGLLABHD6PLA2G7FAAHMAPT
SCHEMBL28447724 0.78 MGLL (0.68) MGLLABHD6PLA2G7FAAHKDM4E
SCHEMBL30141417 0.78 MGLL (0.68) MGLLABHD6PLA2G7FAAHKDM4E
SCHEMBL5331677 0.77 MGLL (0.68) MGLLABHD6PLA2G7FAAHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7291619-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-11-06 US disclosed
US-7291619-B2 Melanocortin receptor agonists ELI LILLY AND COMPANY (US) 2007-11-06 US disclosed
EP-1368340-B1 PIPERAZINE DERIVATIVES AS MELANOCORTIN RECEPTOR AGONISTS LILLY CO ELI (US) 2005-08-10 EP disclosed
US-20040092507-A1 Melanocortin receptor agonists ELI LILLY AND COMPANY 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092507-A1 Melanocortin receptor agonists MC1R, MC4R, MC5R MGLL 986/4885ABHD6 1367/4885PLA2G7 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.